Honduran Copan Coffee (Coffea arabica 'Honduran Copan')
Honduran Copan Coffee (Coffea arabica 'Honduran Copan') is a regional arabica cultivar grown in the Copán department of Honduras, containing chlorogenic acids as its primary bioactive compounds. These polyphenols inhibit glucose-6-phosphatase and modulate AMPK pathways, contributing to antioxidant and potential metabolic effects common to Coffea arabica varieties.

Origin & History
Honduran Copan Coffee (Coffea arabica 'Honduran Copan') is a cultivar variant grown in the Copán region of western Honduras at altitudes of 1,000-1,800 meters above sea level, where volcanic soils and unique microclimate contribute to its quality. Introduced to Honduras in the 1700s, the beans are processed via washed, natural, or honey methods and belong to the chemical class of plant-derived polyphenols and alkaloids inherent to coffee beans.
Historical & Cultural Context
No evidence of historical or traditional medicinal use for Honduran Copan Coffee was found in any traditional medicine systems. Since the 1700s, sources focus solely on culinary and commercial beverage use, with modern emphasis on sustainable farming practices rather than ethnomedicinal applications.
Health Benefits
• No specific health benefits documented - No human clinical trials exist for this cultivar variant • General coffee benefits may apply - Studies on Coffea arabica show reduced risk of type 2 diabetes (evidence quality: not specific to this cultivar) • Potential antioxidant activity - Contains chlorogenic acids common to coffee (evidence quality: theoretical, unstudied for this variant) • May support alertness - Contains caffeine at typical Arabica levels of 1-1.5% dry weight (evidence quality: general coffee data only) • Possible metabolic effects - General coffee research suggests glucose metabolism modulation (evidence quality: no cultivar-specific data)
How It Works
Chlorogenic acids in Coffea arabica, including 5-caffeoylquinic acid (5-CQA), inhibit hepatic glucose-6-phosphatase, reducing postprandial blood glucose levels. Caffeine, present at approximately 1.2–1.5% dry weight in arabica cultivars, antagonizes adenosine A1 and A2A receptors in the central nervous system, increasing dopamine and norepinephrine signaling. Additionally, polyphenolic compounds activate Nrf2 transcription pathways, upregulating endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase.
Scientific Research
No human clinical trials, RCTs, or meta-analyses specific to Honduran Copan Coffee were identified in PubMed-indexed studies. All available research pertains to general Coffea arabica species rather than this specific cultivar variant.
Clinical Summary
No human clinical trials have been conducted specifically on the Honduran Copan cultivar, making direct evidence for this variety absent. Broader Coffea arabica research, including a meta-analysis of 28 prospective cohort studies (n > 1 million participants), associates habitual coffee consumption with a 25–30% reduced risk of type 2 diabetes. A systematic review of 36 studies found 3–5 cups of arabica coffee daily associated with reduced all-cause mortality, though these findings are not attributable to any single cultivar. Evidence quality for Honduran Copan specifically is rated very low, and any attributed benefits are extrapolated from general arabica research.
Nutritional Profile
Honduran Copan Coffee (Coffea arabica 'Honduran Copan') nutritional composition is based on Coffea arabica green and roasted bean data, with cultivar-specific concentrations extrapolated from Honduran specialty coffee research. Per 240ml brewed cup (using ~10g ground coffee): Calories: 2-5 kcal; Macronutrients: Protein 0.3g (negligible bioavailability in brewed form), Carbohydrates 0g net (trace polysaccharides pass into brew), Fat 0.05g (diterpenes cafestol and kahweol present, filtered in paper-brewed methods, ~0.2-0.6mg/cup when filtered; up to 4-6mg/cup in unfiltered methods). Caffeine: Arabica beans typically contain 1.2-1.5% caffeine by dry weight; Copan region beans reported at approximately 1.1-1.3% caffeine, yielding roughly 80-120mg per 240ml brewed cup depending on roast and brew method. Chlorogenic acids (CGAs): primary bioactive compounds; green Arabica beans contain 6-10% CGAs by dry weight, predominantly 5-caffeoylquinic acid (5-CQA); a brewed cup delivers approximately 70-200mg total CGAs, with lighter roasts preserving higher concentrations. Trigonelline: approximately 0.6-1.0% in green bean, partially converted to niacin (vitamin B3) during roasting; brewed cup yields approximately 50-100mg trigonelline and 0.5-1.0mg niacin. Minerals per 240ml cup: Potassium 116mg (moderate bioavailability), Magnesium 7mg, Phosphorus 7mg, Manganese 0.1mg, trace amounts of Copper, Zinc, and Chromium. Vitamins: Riboflavin (B2) approximately 0.2mg per cup; Niacin equivalents 0.5-1.5mg per cup post-roast conversion from trigonelline. Melanoidins: formed during Maillard reaction in roasting; estimated 25-35% of roasted bean dry weight; function as antioxidants and prebiotics with moderate bioavailability. Cafestol and Kahweol (diterpene alcohols): Copan arabica estimated at 3-6mg/g lipid fraction; paper filtration removes >95% of these compounds. Copan-region specific note: High-altitude cultivation (1,200-1,500m in Copan department) is associated with higher sucrose retention (6-9% green bean dry weight), contributing to sweetness and potentially higher antioxidant precursor levels compared to lower-altitude Arabica; exact cultivar-specific micronutrient deviations from standard Arabica are not independently published. Bioavailability notes: CGAs are 30-67% absorbed in the small intestine; remaining fraction fermented by colonic microbiota; caffeine bioavailability near 100%; mineral bioavailability moderate, partially reduced by polyphenol binding.
Preparation & Dosage
No clinically studied dosage ranges exist for Honduran Copan Coffee in biomedical contexts. General coffee consumption typically ranges from 3-5 cups daily (approximately 300-500 mg caffeine), but this lacks standardization or study-specific data for this cultivar. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
L-theanine, Green tea extract, Rhodiola rosea, B-complex vitamins, Magnesium
Safety & Interactions
Caffeine from Honduran Copan Coffee can cause insomnia, tachycardia, anxiety, and elevated blood pressure at intakes exceeding 400 mg/day in healthy adults, per FDA guidance. It inhibits CYP1A2 enzyme activity and may interact with fluoroquinolone antibiotics, clozapine, and theophylline by slowing their hepatic clearance. Pregnant individuals should limit caffeine intake to under 200 mg/day (approximately 1–2 cups), as higher amounts are associated with increased risk of low birth weight and miscarriage. Those with hypertension, GERD, or anxiety disorders should use caution, as caffeine can exacerbate these conditions.